In our chosen profession, patients come first. For care to be optimized, work environments need to be safe and supportive. We believe this is possible through productive discussions held in good faith between a workforce and its employers, to reach a fair and much-needed resolution to the grievances of America’s pharmacists.

Our profession is experiencing unprecedented rates of burnout and even a great migration of oncology pharmacists away from patient care roles. This problem is so endemic that HOPA has established a Wellness Task Force to help combat burnout among our members. And still, more can be done.

We know that addressing the wide, systemic concerns among pharmacists, pharmacy technicians, and other healthcare workers does not come with a simple solution. But we also know pharmacists and pharmacies have a shared goal of providing the best patient care possible.

Some initial promising steps have been taken, and we hope this continues for the good of patient care. We support all pharmacists, regardless of setting or specialty, and hope for a swift and satisfactory resolution to industrial actions being taken today.

U.S. Capitol Building
Advocacy

What HOPA Members Should Know About the End of the 2025 U.S. Government Shutdown

On Wednesday, November 12, Congress passed a continuing resolution to re-open the government after a record 43-day shutdown. Here's what HOPA members should know about the bill and what's happening next.

Map of the sub-Saharan African region
Advocacy

HOPA Endorses ISOPP & UICC Statement on Ensuring International Cancer Drug Quality and Equity

ISOPP and UICC recently released a statement calling for quality and equity of cancer treatments in sub-Saharan Africa. HOPA has joined with oncology and pharmacy organizations worldwide to endorse their statement.

Images of DNA strands for DPYD genetic testing
Advocacy

HOPA Supports FDA Box Label Changes for DPYD Testing

We support the FDA's updated guidance concerning DPD deficiency and fluoropyrimidine drugs, and urge healthcare providers to integrate DPYD genetic testing into clinical practice.